200HO11669 MOLIERE

Print/PDF
Registration Name PROGENESIS MOLIERE-ET
Registration Number HOCAN000111074181
Primary NAAB Code 200HO11669
Secondary Code(s) 777HO11669
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 6/7/2018
aAa 324516
DMS 345,234
GFI 12.9%
Genetic Codes * TR TL TD TP TC TE
Haplotypes HH1T, HH2C, HH3T, HH4T, HH5T, HH6T
Sire PROGENESIS TOPNOTCH-ET
MGS SILVERRIDGE V EUGENIO-ET
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin -
INDEXES
NM$ 164, 90% R CM$ 176
NM Percentile 23% FM$ 138
GTPI 2793 GM$ 163
PRODUCTION TRAITS
4706 Dtrs 1217 herds 9 % US 98% R
Milk 817 Fat, % 14 , -0.07%
SCS 2.86, 97% R Protein, % 31 , +0.02%
Feed Saved -101 , 57% R Milking Speed 6.91 , 78% R
Health & Fertility
Productive Life -0.2      96% R Mastitis -0.2      88% R
Heifer Livability 0.3       70% R Metritis -0.1      79% R
Livability -1.4      84% R D. Abom -0.5      84% R
DPR -       97% R Ketosis 0.7      78% R
FSC -2.1      97% R R. Placenta -1.1      82% R
HCR -1.0      92% R Milk Fever -0.2      69% R
CCR -       96% R
SCR -        -
DIA 0.6      45% R
RSP -0.6      59% R
Calving Traits
Sire CE 1.3      92% R 4920 Obs
Daughter CE 1.4      91% R 442 Obs, 3329 Dtrs
Sire SB 3.8      84% R 5781 Obs
Daughter SB 3.3      91% R 442 Obs, Dtrs
Gestation Length -2.0      97% R 42 Obs, 325 Dtrs
Early First Calving 5.1      92% R 47 Obs, 382 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
3329 Dtrs 933 herds 95% R
PTA Type 1.00 UDC 1.09
HCC 0.65 BWC 0.87
FLC -0.55
Linear Traits
Stature 1.47
Tall
Strength 0.47
Strong
Body Depth 0.49
Deep
Dairy Form 0.01
Open
Rump Angle -0.23
Flat
Thurl Width 0.94
Flat
Rear Legs-Side View 0.94
Wide
Rear Legs-Rear View -0.37
H.-in
Foot Angle 0.76
Steep
Feet & Legs Score -0.22
Low
F.U. Attachment -0.12
Straight
Rear Udder Height 1.49
High
Rear Udder Width 0.86
Wide
Udder Cleft 1.24
Strong
Udder Depth -0.37
H.-in
Front Teat Placement -0.45
Wide
Rear Teat Placement 0.60
Close
Teat Length 1.59
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO